BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28352151)

  • 1. Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up.
    Chang DF; Donnenfeld ED; Katz LJ; Voskanyan L; Ahmed II; Samuelson TW; Giamporcaro JE; Hornbeak DM; Solomon KD
    Clin Ophthalmol; 2017; 11():523-528. PubMed ID: 28352151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Evaluation of Two iStent
    Myers JS; Masood I; Hornbeak DM; Belda JI; Auffarth G; Jünemann A; Giamporcaro JE; Martinez-de-la-Casa JM; Ahmed IIK; Voskanyan L; Katz LJ
    Adv Ther; 2018 Mar; 35(3):395-407. PubMed ID: 29476443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up.
    Lindstrom R; Lewis R; Hornbeak DM; Voskanyan L; Giamporcaro JE; Hovanesian J; Sarkisian S
    Adv Ther; 2016 Nov; 33(11):2082-2090. PubMed ID: 27739003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma.
    Saheb H; Donnenfeld ED; Solomon KD; Voskanyan L; Chang DF; Samuelson TW; Ahmed IIK; Katz LJ
    Curr Eye Res; 2021 Feb; 46(2):224-231. PubMed ID: 32715828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantation of two second-generation trabecular micro-bypass stents and topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 18-month follow-up.
    Berdahl J; Voskanyan L; Myers JS; Hornbeak DM; Giamporcaro JE; Katz LJ; Samuelson TW
    Clin Exp Ophthalmol; 2017 Nov; 45(8):797-802. PubMed ID: 28384377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes.
    Berdahl J; Voskanyan L; Myers JS; Katz LJ; Samuelson TW
    Clin Exp Ophthalmol; 2020 Aug; 48(6):767-774. PubMed ID: 32311201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes.
    Katz LJ; Erb C; Carceller Guillamet A; Fea AM; Voskanyan L; Giamporcaro JE; Hornbeak DM
    Clin Ophthalmol; 2018; 12():255-262. PubMed ID: 29440867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-Year, Prospective, Randomized, Multi-Surgeon Trial of Two Trabecular Bypass Stents versus Prostaglandin for Newly Diagnosed Open-Angle Glaucoma.
    Fechtner RD; Voskanyan L; Vold SD; Tetz M; Auffarth G; Masood I; Au L; Khouri AS; Ahmed IIK; Saheb H
    Ophthalmol Glaucoma; 2019; 2(3):156-166. PubMed ID: 32672584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.
    Samuelson TW; Sarkisian SR; Lubeck DM; Stiles MC; Duh YJ; Romo EA; Giamporcaro JE; Hornbeak DM; Katz LJ;
    Ophthalmology; 2019 Jun; 126(6):811-821. PubMed ID: 30880108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-Year Outcomes of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication.
    Lindstrom R; Sarkisian SR; Lewis R; Hovanesian J; Voskanyan L
    Clin Ophthalmol; 2020; 14():71-80. PubMed ID: 32021070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective 3-year follow-up trial of implantation of two trabecular microbypass stents in open-angle glaucoma.
    Donnenfeld ED; Solomon KD; Voskanyan L; Chang DF; Samuelson TW; Ahmed II; Katz LJ
    Clin Ophthalmol; 2015; 9():2057-65. PubMed ID: 26604675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication.
    Katz LJ; Erb C; Carceller GA; Fea AM; Voskanyan L; Wells JM; Giamporcaro JE
    Clin Ophthalmol; 2015; 9():2313-20. PubMed ID: 26715834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, unmasked evaluation of the iStent® inject system for open-angle glaucoma: synergy trial.
    Voskanyan L; García-Feijoó J; Belda JI; Fea A; Jünemann A; Baudouin C;
    Adv Ther; 2014 Feb; 31(2):189-201. PubMed ID: 24452726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study.
    Hengerer FH; Auffarth GU; Riffel C; Conrad-Hengerer I
    Adv Ther; 2019 Jul; 36(7):1606-1617. PubMed ID: 31119690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of microinvasive glaucoma surgery with trabecular microbypass stents and prostaglandin in open-angle glaucoma.
    Ahmed II; Katz LJ; Chang DF; Donnenfeld ED; Solomon KD; Voskanyan L; Samuelson TW
    J Cataract Refract Surg; 2014 Aug; 40(8):1295-300. PubMed ID: 25088627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iStent inject Trabecular Micro-Bypass with or Without Cataract Surgery Yields Sustained 5-Year Glaucoma Control.
    Hengerer FH; Auffarth GU; Conrad-Hengerer I
    Adv Ther; 2022 Mar; 39(3):1417-1431. PubMed ID: 35113323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months.
    Vold SD; Voskanyan L; Tetz M; Auffarth G; Masood I; Au L; Ahmed II; Saheb H
    Ophthalmol Ther; 2016 Dec; 5(2):161-172. PubMed ID: 27619225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-Generation Trabecular Micro-Bypass (iStent inject) with Cataract Surgery in Eyes with Normal-Tension Glaucoma: One-Year Outcomes of a Multi-Centre Study.
    Salimi A; Clement C; Shiu M; Harasymowycz P
    Ophthalmol Ther; 2020 Sep; 9(3):585-596. PubMed ID: 32613589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent Inject) Implantation with Cataract Surgery in Different Glaucoma Subtypes and Severities.
    Salimi A; Lapointe J; Harasymowycz P
    Ophthalmol Ther; 2019 Dec; 8(4):563-575. PubMed ID: 31538316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trabecular micro-bypass stent implantation during small-incision cataract surgery for open-angle glaucoma or ocular hypertension: Long-term results.
    Neuhann TH
    J Cataract Refract Surg; 2015 Dec; 41(12):2664-71. PubMed ID: 26796447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.